Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Cogstate Ltd ( (AU:CGS) ) has shared an update.
Cogstate Limited has reported changes to director Martyn Myer’s interests in the company’s ordinary shares, reflecting a reallocation of holdings across a mix of direct and indirect entities, including family trusts, superannuation funds, and related parties. The adjustments, dated primarily 12 April 2026, indicate internal restructuring of Myer’s ownership rather than a disclosed change in overall board composition or corporate strategy, but they may be monitored by investors for signals about long-term alignment and governance.
These changes cover multiple vehicles such as Mpyer Investments, Whereabouts Superannuation Fund, and other family-related entities that previously held or now hold Cogstate shares. While the notice does not specify any impact on Cogstate’s operations, it formalizes the updated pattern of beneficial ownership for regulatory transparency and may inform market perceptions of insider positioning and confidence in the company’s future performance.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$3.20 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Limited is an Australian-listed company that operates in the cognitive science and diagnostics sector. The company provides computerized cognitive assessment tools and related services that are used in clinical trials, healthcare settings, and research to measure and monitor cognitive function across various therapeutic areas.
Average Trading Volume: 191,625
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$393.3M
For a thorough assessment of CGS stock, go to TipRanks’ Stock Analysis page.